Different intensities of glycaemic control for pregnant women with pre-existing diabetes

Published on May 4, 2016in Cochrane Database of Systematic Reviews7.89
· DOI :10.1002/14651858.CD008540.PUB4
Philippa Middleton69
Estimated H-index: 69
(Boston Children's Hospital),
Caroline A Crowther84
Estimated H-index: 84
(University of Auckland)
+ 0 AuthorsLucy A Simmonds5
Estimated H-index: 5
(UniSA: University of South Australia)
Background The optimal glycaemic control target in pregnant women with pre-existing diabetes is unclear, although there is a clear link between high glucose concentrations and adverse birth outcomes. Objectives To assess the effects of different intensities of glycaemic control in pregnant women with pre-existing type 1 or type 2 diabetes. Search methods We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 January 2016) and planned to search reference lists of retrieved studies. Selection criteria We included randomised controlled trials comparing different glycaemic control targets in pregnant women with pre-existing diabetes. Data collection and analysis Two review authors independently assessed trials for inclusion, conducted data extraction, assessed risk of bias and checked for accuracy. We assessed the quality of the evidence using the GRADE approach. Main results We included three trials, all in women with type 1 diabetes (223 women and babies). All three trials were at high risk of bias due to lack of blinding, unclear methods of randomisation and selective reporting of outcomes. Two trials compared very tight (3.33 to 5.0 mmol/L fasting blood glucose (FBG)) with tight-moderate (4.45 to 6.38 mmol/L) glycaemic control targets, with one trial of 22 babies reporting no perinatal deaths orserious perinatal morbidity (evidence graded low for both outcomes). In the same trial, there were two congenital anomalies in the very tight, and none in the tight-moderate group, with no significant differences in caesarean section between groups (risk ratio (RR) 0.92, 95% confidence interval (CI) 0.49 to 1.73; evidence graded very low). In these two trials, glycaemic control was not significantly different between the very tight and tight-moderate groups by the third trimester, although one trial of 22 women found significantly less maternal hypoglycaemia in the tight-moderate group. In a trial of 60 women and babies comparing tight (≤ 5.6 mmol/L FBG); moderate (5.6 to 6.7 mmol/L); and loose (6.7 to 8.9 mmol/L) glycaemic control targets, there were two neonatal deaths in the loose and none in the tight or moderate groups (evidence graded very low). There were significantly fewer women with pre-eclampsia (evidence graded low), fewer caesarean sections (evidence graded low) and fewer babies with birthweights greater than 90th centile (evidence graded low) in the combined tight-moderate compared with the loose group. The quality of the evidence was graded low or very low for important outcomes, because of design limitations to the studies, the small numbers of women included, and wide confidence intervals crossing the line of no effect. Many of the important outcomes were not reported in these studies. Authors' conclusions In a very limited body of evidence, few differences in outcomes were seen between very tight and tight-moderate glycaemic control targets in pregnant women with pre-existing type 1 diabetes, including actual glycaemic control achieved. There is evidence of harm (increased pre-eclampsia, caesareans and birthweights greater than 90th centile) for 'loose' control (FBG above 7 mmol/L). Future trials comparing interventions, rather than glycaemic control targets, may be more feasible. Trials in pregnant women with pre-existing type 2 diabetes are required.
📖 Papers frequently viewed together
3,223 Citations
142 Citations
8 Authors (Mary Macintosh, ..., Alison Miller)
498 Citations
#1Foong Ming Moy (UM: University of Malaya)H-Index: 22
#2Amita RayH-Index: 4
Last. Helen M West (University of Liverpool)H-Index: 12
view all 4 authors...
Background Self-monitoring of blood glucose (SMBG) is recommended as a key component of the management plan for diabetes therapy during pregnancy. No existing systematic reviews consider the benefits/effectiveness of various techniques of blood glucose monitoring on maternal and infant outcomes among pregnant women with pre-existing diabetes. The effectiveness of the various monitoring techniques is unclear. Objectives To compare techniques of blood glucose monitoring and their impact on materna...
29 CitationsSource
#1Diane Farrar (Bradford Royal Infirmary)H-Index: 18
#2Derek Tuffnell (Bradford Royal Infirmary)H-Index: 29
Last. Helen M West (University of Liverpool)H-Index: 12
view all 4 authors...
Background Diabetes results in a rise in blood glucose above normal physiological levels; if untreated this may cause damage to many systems including the cardiovascular and renal systems. Pregnancy increases resistance to insulin action; for those women who have pre-gestational diabetes, this results in an increasing insulin requirement. There are several methods of administering insulin. Conventionally, insulin has been administered subcutaneously, formally referred to as intensive conventiona...
110 CitationsSource
#1Yeyi Zhu (NIH: National Institutes of Health)H-Index: 19
#2Cuilin Zhang (NIH: National Institutes of Health)H-Index: 68
Despite the increasing epidemic of diabetes mellitus affecting populations at different life stages, the global burden of gestational diabetes mellitus (GDM) is not well assessed. Systematically synthesized data on global prevalence estimates of GDM are lacking, particularly among developing countries. The hyperglycemic intrauterine environment as exemplified in pregnancies complicated by GDM might not only reflect but also fuel the epidemic of type 2 diabetes mellitus (T2DM). We comprehensively...
420 CitationsSource
#1Ma Cristina G Pelaez-Crisologo (UP: University of the Philippines)H-Index: 1
#2Maria Geraldine Assumption Gavina N Castillo-Torralba (UP: University of the Philippines)H-Index: 1
Last. Mario Festin (WHO: World Health Organization)H-Index: 16
view all 3 authors...
Reason for Withdrawal This protocol is now out of date and has been withdrawn from publication in the Cochrane Library. To view the published versions of this article, please click the 'Other versions' tab.
4 CitationsSource
#1Jonathan Webber (University Hospitals Birmingham NHS Foundation Trust)H-Index: 5
#2Mary Charlton (University Hospitals Birmingham NHS Foundation Trust)H-Index: 1
Last. Nina JohnsH-Index: 1
view all 3 authors...
In February 2015 the National Institute for Health and Care Excellence (NICE) published new guidance (NG3) on the management of diabetes in pregnancy. Care teams need to be aware of this guidance and implement its recommendations. These include preconception care with target HbA1c 48 mmol/mol. Women at risk of gestational diabetes mellitus (GDM) should have a 75 g oral glucose tolerance test (OGTT). Diagnostic criteria for GDM have changed to fasting glucose of 5.6 mmol/L or above or 2 hour gluc...
173 CitationsSource
#1Bianca Hemmingsen (Copenhagen University Hospital)H-Index: 13
#2Søren S Lund (Boehringer Ingelheim)H-Index: 25
Last. Jørn Wetterslev (Copenhagen University Hospital)H-Index: 82
view all 6 authors...
Background Patients with type 2 diabetes mellitus (T2D) have an increased risk of cardiovascular disease and mortality compared to the background population. Observational studies report an association between reduced blood glucose and reduced risk of both micro- and macrovascular complications in patients with T2D. Our previous systematic review of intensive glycaemic control versus conventional glycaemic control was based on 20 randomised clinical trials that randomised 29 ,986 participants wi...
227 CitationsSource
#1Partha Sardar (UofU: University of Utah)H-Index: 25
#2Jacob A. Udell (UHN: University Health Network)H-Index: 32
Last. Michael E. Farkouh (UHN: University Health Network)H-Index: 61
view all 6 authors...
Background Regional variation in type 2 diabetes mellitus care may affect outcomes in patients treated with intensive versus standard blood glucose control. We sought to evaluate these differences between North America and the rest of the world. Methods and Results Databases were searched from their inception through December 2013. Randomized controlled trials comparing the effects of intensive therapy with standard therapy for macro‐ and microvascular complications in adults with type 2 diabete...
26 CitationsSource
#1L Owens (National University of Ireland, Galway)H-Index: 10
#2Jon SedarH-Index: 1
Last. Fidelma Dunne (National University of Ireland, Galway)H-Index: 43
view all 4 authors...
Pregnancy in women with type 1 (T1DM) or type 2 diabetes (T2DM) is associated with increased risk. These conditions are managed similarly during pregnancy, and compared directly in analyses, however they affect women of different age, body mass index and ethnicity.
27 CitationsSource
#1Adolfo Correa (UMMC: University of Mississippi Medical Center)H-Index: 84
#1Adolfo Correa (UMMC: University of Mississippi Medical Center)H-Index: 12
Last. Edward W. Gregg (CDC: Centers for Disease Control and Prevention)H-Index: 107
view all 5 authors...
To describe recent trends in prevalence of pre-existing diabetes mellitus (PDM) (i.e., type 1 or type 2 diabetes) and gestational diabetes mellitus (GDM) among delivery hospitalizations in the United States. Data on delivery hospitalizations from 1993 through 2009 were obtained from the Health Care Cost and Utilization Project (HCUP) Nationwide Inpatient Sample. Diagnosis-Related Group codes were used to identify deliveries and diagnosis codes on presence of diabetes. Rates of hospitalizations w...
78 CitationsSource
1,137 Citations
Cited By35
#1Ashley N. Battarbee (UNC: University of North Carolina at Chapel Hill)H-Index: 8
#2Kartik K. Venkatesh (UNC: University of North Carolina at Chapel Hill)H-Index: 6
Last. Kim A. Boggess (UNC: University of North Carolina at Chapel Hill)H-Index: 41
view all 4 authors...
To estimate the association between maternal diabetes and severe neonatal morbidity. Retrospective cohort study of nonanomalous neonates born 240−416 weeks’ gestation from two large multisite U.S. cohorts, Cesarean Registry and Consortium on Safe Labor. The exposure was pregestational versus gestational versus no diabetes. The composite neonatal outcome included respiratory distress syndrome, mechanical ventilation, necrotizing enterocolitis, grade 3-4 intraventricular hemorrhage, and death. Mul...
13 CitationsSource
#1Jonas F. Ludvigsson (Columbia University)H-Index: 81
#2Martin Neovius (KI: Karolinska Institutet)H-Index: 62
Last. Björn Pasternak (SSI: Statens Serum Institut)H-Index: 32
view all 8 authors...
Background: Maternal type 1 diabetes (T1D) has been linked to preterm birth and other adverse pregnancy outcomes. How these risks vary with glycated hemoglobin (or hemoglobin A1c [HbA1c]) levels is unclear. Objective: To examine preterm birth risk according to periconceptional HbA1c levels in women with T1D. Design: Population-based cohort study. Setting: Sweden, 2003 to 2014. Patients: 2474 singletons born to women with T1D and 1 165 216 reference infants born to women without diabetes. Measure...
7 CitationsSource
#1Nancy Medley (University of Liverpool)H-Index: 15
#2Joshua P. Vogel (Burnet Institute)H-Index: 54
Last. Zarko Alfirevic (University of Liverpool)H-Index: 76
view all 4 authors...
BACKGROUND: Preterm birth (PTB) is a major factor contributing to global rates of neonatal death and to longer-term health problems for surviving infants. Both the World Health Organization and the United Nations consider prevention of PTB as central to improving health care for pregnant women and newborn babies. Current preventative clinical strategies show varied efficacy in different populations of pregnant women, frustrating women and health providers alike, while researchers call for better...
35 CitationsSource
#1Siobhan Bacon (Mount Sinai Hospital)
#1Siobhán Bacon (U of T: University of Toronto)H-Index: 1
Last. Denice S. Feig (U of T: University of Toronto)H-Index: 28
view all 2 authors...
Purpose of Review To review current glycaemic targets and the potential use of newer insulin formulations in pregnancy.
3 CitationsSource
#1Sofia Nahavandi (University of Melbourne)H-Index: 7
#2Jas-Mine SeahH-Index: 6
Last. Elif I Ekinci (University of Melbourne)H-Index: 25
view all 5 authors...
Large birthweight, or macrosomia, is one of the commonest complications for pregnancies affected by diabetes. As macrosomia is associated with an increased risk of a number of adverse outcomes for both the mother and offspring, accurate antenatal prediction of fetal macrosomia could be beneficial in guiding appropriate models of care and interventions that may avoid or reduce these associated risks. However, current prediction strategies which include physical examination and ultrasound assessme...
10 CitationsSource
Gates Cambridge Scholarship Jean Hailes Foundation Fellowship for Emerging Clinical Leaders in Women's Health
#1Linda Biesty (National University of Ireland, Galway)H-Index: 9
#2Aoife M. Egan (National University of Ireland, Galway)H-Index: 15
Last. Declan Devane (National University of Ireland, Galway)H-Index: 44
view all 8 authors...
National Institute for Health Research (Cochrane Programme Grant funding to Cochrane Pregnancy and Childbirth)
12 CitationsSource
#1Peer-Benedikt Vincent Bussiek (LSE: London School of Economics and Political Science)H-Index: 1
#2Chiara De Poli (LSE: London School of Economics and Political Science)H-Index: 2
Last. Gwyn Bevan (LSE: London School of Economics and Political Science)H-Index: 27
view all 3 authors...
Introduction Obesity has become one of the biggest public health problems of the 21st century. Prevalence of obesity in children and adolescents has increased dramatically worldwide over the last 20 years, and this trend is expected to continue. Obesity in childhood is concerning as it predicts obesity in adulthood, a common risk factor for a wide array of chronic diseases and poor health outcomes. Obesity is preventable and a vast but fragmented body of evidence on preventative interventions is...
11 CitationsSource
#1Linda BiestyH-Index: 9
#2Aoife M. EganH-Index: 3
Last. Declan DevaneH-Index: 3
view all 8 authors...
1 CitationsSource